MTOR and pancreatic neoplasm: In vitro studies have demonstrated diverse effects of mTOR inhibition on cell cycle arrest, autophagy, decreased desmoplastic inflammation, and inhibited epithelial-to-mesenchymal transition in preclinical studies of pancreatic cancer (Table 1).